Tykerb and Herceptin work better together, study suggests
17 January 2012
Sukaina Virji
Please Login to read the full article.
17 January 2012
Sukaina Virji
sukaina.virji@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- GSK's Tykerb again disappoints in adjuvant breast cancer setting
- NICE still down on overall survival benefit of Roche's Herceptin and GSK's Tyverb following appeal
- GSK and Novartis withdraw EU filings in cancer and influenza
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
